Liquid Biopsy Analysis in Clinical Practice: Focus on Lung Cancer

• Váldodahkkit: Pasquale Pisapia (Dahkki), Francesco Pepe (Dahkki), Antonino Iaccarino (Dahkki), Roberta Sgariglia (Dahkki), Mariantonia Nacchio (Dahkki), Gianluca Russo (Dahkki), Gianluca Gragnano (Dahkki), Elalah Mosaieby (Dahkki), Giancarlo Troncone (Dahkki), Umberto Malapelle (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: MDPI AG, 2021-07-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Lung cancer is the leading cause of cancer death worldwide. Despite the emergence of highly effective targeted therapies, up to 30% of advanced stage non-small cell lung cancer (NSCLC) patients do not undergo tissue molecular testing because of scarce tissue availability. Liquid biopsy, on the other...